LOG IN
SIGN UP
News
REVB
1.370
0.00%
0.000
Sarepta Therapeutics, Credit Suisse, First Republic Bank among premarket losers' pack
Seeking Alpha · 6d ago
ThermoGenesis, Elevation top healthcare gainers; VolitionRx, InfuSystem among losers
Seeking Alpha · 03/15 14:08
UBS Group, Banco Santander, Prudential, Credit Suisse among major financial premarket losers' pack
Seeking Alpha · 03/15 12:43
Revelation Biosciences Says On Feb. 16 Received Nasdaq Notice Stating Co.'s Common Stock Will Continue To Be Listed, Traded On Nasdaq
Benzinga · 02/17 21:19
Roth MKM Maintains Buy on Revelation Biosciences, Raises Price Target to $15
Benzinga · 02/14 14:34
--Roth MKM Adjusts Price Target on Revelation Biosciences to $15 From $5, Maintains Buy Rating
--Roth MKM Adjusts Price Target on Revelation Biosciences to $15 From $5, Maintains Buy Rating
MT Newswires · 02/14 10:17
FSLY, BTBT and AFMD are among pre market gainers
Seeking Alpha · 02/13 13:22
Why Revelation Biosciences Is Trading 40% Lower Thursday
Benzinga · 02/09 18:54
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 02/09 17:50
US Stocks Turn Lower; Dow Drops 50 Points
Benzinga · 02/09 17:47
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 02/09 17:31
Revelation stock crashes ~40% on pricing $15.6M stock, warrants offering
Seeking Alpha · 02/09 15:57
Dow Jumps 250 Points; US Jobless Claims Increase Last Week
Benzinga · 02/09 15:42
Cardiovascular Systems, Decibel top healthcare gainers; Revelation, Veru among losers
Seeking Alpha · 02/09 15:00
Update: Revelation Biosciences Prices $15.6 Million Securities Offering; Shares Drop Fourth Consecutive Day
Update: Revelation Biosciences Prices $15.6 Million Securities Offering; Shares Drop Fourth Consecutive Day
MT Newswires · 02/09 14:23
Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/09 13:54
ABEO, KPRX and RGTI among pre market losers
Seeking Alpha · 02/09 13:49
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/09 13:06
Revelation Biosciences Prices $15.6 Million Securities Offering; Shares Plunge
Revelation Biosciences Prices $15.6 Million Securities Offering; Shares Plunge
MT Newswires · 02/09 10:57
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 02/08 21:31
More
Webull provides a variety of real-time REVB stock news. You can receive the latest news about Rvltn Bioscnc through multiple platforms. This information may help you make smarter investment decisions.
About REVB
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immunologic therapeutics and diagnostics. Its therapeutic product candidates are based on its therapeutic platform and consist of REVTx-100, which is being developed for the prevention or treatment of infections, including those resulting from surgery, severe burns and antibiotic resistance; REVTx-200, which is being developed as intranasal therapy that focuses to be administered with a commercially available intramuscular (IM) vaccine; REVTx-300, which is being developed as a therapy for the treatment of chronic organ disease, including CKD and NASH; and REVTx-99b, which is being developed for the treatment of food allergies. The Company's diagnostic, REVDx-501 (REVIDTM Rapid Test Kit), is being developed as a rapid point of care or at home diagnostic product that can potentially be used to detect various respiratory viral infections.